NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022

J. Caudell, Jimmy; L. Gillison, Maura; Maghami, Ellie; Spencer, Sharon; G. Pfister, David; Adkins, Douglas; C. Birkeland, Andrew; M. Brizel, David; M. Busse, Paul; J. Cmelak, Anthony; Dimitrios Colevas, A.; W. Eisele, David; Galloway, Thomas; L. Geiger, Jessica; I. Haddad, Robert; L. Hicks, Wesley; J. Hitchcock, Ying; Jimeno, Antonio; Leizman, Debra; K. Mell, Loren; B. Mittal, Bharat; A. Pinto, Harlan; W. Rocco, James; P. Rodriguez, Cristina; S. Savvides, Panayiotis; Schwartz, David; P. Shah, Jatin; Sher, David; St. John, Maie; S. Weber, Randal; Weinstein, Gregory; Worden, Frank; Yang Bruce, Justine; S. Yom, Sue; Zhen, Weining; L. Burns, Jennifer; D. Darlow, Susan

doi:10.6004/jnccn.2022.0016

Public

NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022

Shared by NobleBlocks on Mar 1, 2022 • 12:00 AM UTC

Authors:

Jimmy J. Caudell

Maura L. Gillison

Ellie Maghami

Abstract

The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed. The specific site of disease, stage, and pathologic fin...

Discussions